McKesson Corporation (MCK) : Pure Financial Advisors reduced its stake in McKesson Corporation by 20.06% during the most recent quarter end. The investment management company now holds a total of 1,992 shares of McKesson Corporation which is valued at $330,313 after selling 500 shares in McKesson Corporation , the firm said in a disclosure report filed with the SEC on Oct 7, 2016.McKesson Corporation makes up approximately 0.11% of Pure Financial Advisors’s portfolio.
Other Hedge Funds, Including , Nadler Financial Group boosted its stake in MCK in the latest quarter, The investment management firm added 7 additional shares and now holds a total of 1,337 shares of McKesson Corporation which is valued at $221,701. McKesson Corporation makes up approx 0.09% of Nadler Financial Group’s portfolio. Eqis Capital Management sold out all of its stake in MCK during the most recent quarter. The investment firm sold 1,663 shares of MCK which is valued $275,509.Cullinan Associates Inc boosted its stake in MCK in the latest quarter, The investment management firm added 2,700 additional shares and now holds a total of 7,250 shares of McKesson Corporation which is valued at $1,201,108. McKesson Corporation makes up approx 0.10% of Cullinan Associates Inc’s portfolio.Harbour Capital Advisors reduced its stake in MCK by selling 3,765 shares or 49.53% in the most recent quarter. The Hedge Fund company now holds 3,836 shares of MCK which is valued at $635,510. McKesson Corporation makes up approx 0.34% of Harbour Capital Advisors’s portfolio. Beacon Financial Group added MCK to its portfolio by purchasing 4,200 company shares during the most recent quarter which is valued at $695,814. McKesson Corporation makes up approx 0.15% of Beacon Financial Group’s portfolio.
McKesson Corporation opened for trading at $165.39 and hit $166.9 on the upside on Friday, eventually ending the session at $165.82, with a gain of 0.65% or 1.07 points. The heightened volatility saw the trading volume jump to 12,56,893 shares. Company has a market cap of $37,426 M.
On the company’s financial health, McKesson Corporation reported $3.50 EPS for the quarter, beating the analyst consensus estimate by $ 0.16 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $3.34. The company had revenue of $49733.00 million for the quarter, compared to analysts expectations of $50333.03 million. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.14 EPS.
Many Wall Street Analysts have commented on McKesson Corporation. Shares were Reiterated by Mizuho on Sep 26, 2016 to “Neutral” and Lowered the Price Target to $ 183 from a previous price target of $197 .McKesson Corporation was Downgraded by Goldman to ” Neutral” on Sep 16, 2016. Company shares were Reiterated by Mizuho on Aug 11, 2016 to “Neutral”, Firm has raised the Price Target to $ 197 from a previous price target of $174 .
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.